An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Eileen L. | - |
dc.contributor.author | Yeon, Jong Eun | - |
dc.contributor.author | Ko, Eunjung | - |
dc.contributor.author | Lee, Hyun Jung | - |
dc.contributor.author | Je, Ji Hye | - |
dc.contributor.author | Yoo, Yang Jae | - |
dc.contributor.author | Kang, Seong Hee | - |
dc.contributor.author | Suh, Sang Jun | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Seo, Yeon Seok | - |
dc.contributor.author | Yim, Hyung Joon | - |
dc.contributor.author | Byun, Kwan Soo | - |
dc.date.accessioned | 2021-09-03T09:46:30Z | - |
dc.date.available | 2021-09-03T09:46:30Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-02 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/84513 | - |
dc.description.abstract | The prognostic role of aberrant serum miRNA expression for predicting response to sorafenib treatment in advanced hepatocellular carcinoma (HCC) patients has not been well characterized. We aimed to identify specific serum miRNAs that are associated with positive radiologic responses or improved survival in sorafenib-treated HCC patients. miR-18a, miR-21, miR-139-5p, miR-221, miR-224, and miR-10b-3p, were selected for analysis. Serum samples from 24 patients with advanced stage HCC and 25 patients with liver cirrhosis (LC) were analyzed. All of the miRNAs except miR-21 were found to be upregulated in serum samples from HCC patients. None of the miRNAs assayed differed significantly in terms of expression between the responder and non-responder groups among HCC patients. However, miR-10b-3p levels were significantly higher in the subgroup of HCC patients with worse overall survival (fold change = 5.8, P = 0.008). Serum miRNA-10b-3p was upregulated in the presence of macrovascular invasion (MVI), and those with higher serum miRNA-10b-3p had significantly shorter survival during treatment (P = 0.042). Although no single serum miRNA was predictive of response to sorafenib treatment, analysis of serum miR-10b-3p levels may be valuable for diagnosis of HCC and prediction of survival of sorafenib-treated patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | MICRORNA EXPRESSION | - |
dc.subject | CIRCULATING MICRORNAS | - |
dc.subject | CANCER | - |
dc.subject | METASTASIS | - |
dc.subject | HEPATITIS | - |
dc.subject | PROMOTES | - |
dc.subject | CONTRIBUTES | - |
dc.subject | APOPTOSIS | - |
dc.subject | MIGRATION | - |
dc.subject | INVASION | - |
dc.title | An Explorative Analysis for the Role of Serum miR-10b-3p Levels in Predicting Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yeon, Jong Eun | - |
dc.contributor.affiliatedAuthor | Kim, Ji Hoon | - |
dc.contributor.affiliatedAuthor | Seo, Yeon Seok | - |
dc.contributor.affiliatedAuthor | Yim, Hyung Joon | - |
dc.contributor.affiliatedAuthor | Byun, Kwan Soo | - |
dc.identifier.doi | 10.3346/jkms.2017.32.2.212 | - |
dc.identifier.scopusid | 2-s2.0-85011636509 | - |
dc.identifier.wosid | 000392204500008 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.32, no.2, pp.212 - 220 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 32 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 212 | - |
dc.citation.endPage | 220 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002192363 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | MICRORNA EXPRESSION | - |
dc.subject.keywordPlus | CIRCULATING MICRORNAS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | HEPATITIS | - |
dc.subject.keywordPlus | PROMOTES | - |
dc.subject.keywordPlus | CONTRIBUTES | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | INVASION | - |
dc.subject.keywordAuthor | Serum MicroRNA | - |
dc.subject.keywordAuthor | Hepatocellular Carcinoma | - |
dc.subject.keywordAuthor | Sorafenib | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Macrovascular Invasion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.